Key result
US pulmonary embolism and cardiovascular disease mortality increased ~1.4% annually from 1999 to 2023.
Observational (n=497,660)
Answers are grounded in this paper and cite their sources.
Mortality due to pulmonary embolism and cardiovascular disease in the U.S. has increased significantly from 1999 to 2023, highlighting notable demographic and geographic disparities.
Pulmonary Embolism (PE) and Cardiovascular disease (CVD) are the major causes of morbidity and mortality in the U.S. Cardiovascular complications and thromboembolic events in affected patients may arise from underlying disease processes or treatment-related factors. Stratified analysis of PE and CVD-related mortality in patients by demographic and geographical categorization is limited, and by this study, we aim to analyze these trends in the United States.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) conducted an observational in Pulmonary Embolism and Cardiovascular Disease (n=497,660). Year of death (1999-2023) was evaluated on Overall trend in age-adjusted mortality rate (AAMR) (AAPC 1.4%). Mortality due to pulmonary embolism and cardiovascular disease in the United States increased from 1999 to 2023 with an overall average annual percent change of 1.4%.
Synapse has enriched 10 related papers. Consider them for comparative context: